Early Life
Marc Rubiralta was born in Spain. He is the son of Josep María Rubiralta, who co-founded Werfen with his uncle Francisco in 1963. His father's entrepreneurial spirit laid the foundation for Marc's future in the diagnostics industry.
Rise to Success
Marc Rubiralta's career began with a degree in Business Administration and Management from ESADE. He gained experience at Deloitte before joining Werfen, where he served as Chief Financial Officer in both Spain and China. His financial acumen and leadership skills led to his appointment as Chairman of the Medical Devices division and a member of the Executive Committee. In 2019, Marc Rubiralta became the President of Werfen, succeeding his brother Jordi Rubiralta, and has been instrumental in driving the company's growth through strategic acquisitions and expansion.
Key Business Strategies
Under Marc Rubiralta's leadership, Werfen has focused on expanding its global presence and enhancing its product portfolio. A significant strategic move was the $2 billion acquisition of U.S.-based Immucor, a leading company in transfusion and transplantation diagnostics. This acquisition strengthened Werfen's position in the in vitro diagnostics (IVD) market, particularly in hemostasis, acute care, and autoimmunity diagnostics. The company has also invested in R&D to bring new products to market, improving care and overall efficiencies in the healthcare industry.
Philanthropy
While specific details of Marc Rubiralta's philanthropic initiatives are not readily available, his family is known to be involved in various social and economic activities through the Family Council.
